Keytruda for Colorectal Cancer User Reviews
Keytruda has an average rating of 6.3 out of 10 from a total of 3 reviews for the treatment of Colorectal Cancer. 67% of reviewers reported a positive experience, while 33% reported a negative experience.
- Steven
- Taken for 6 months to 1 year
- May 20, 2024
"Very successful. 8 months of infusion every 3 weeks. Few side effects. Initially experienced coldness in body. Now experiencing profuse sweating when calm. Scaly, itchy skin on palms of hands and bottom of feet. Treatment ended mid-January 2024"
- Charlie
- Taken for 2 to 5 years
- January 24, 2023
"Keytruda wiped out most of my colon cancer and I’ve been in full remission for well over 3 years."
Frequently asked questions
- How long does it take for Keytruda to work?
- What is the success rate of Keytruda?
- What are monoclonal antibodies?
- What is the difference between Opdivo and Keytruda?
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
Learn more about Colorectal Cancer
Care guides
Symptoms and treatments
Medicine.com guides (external)
More about Keytruda (pembrolizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (214)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
"My doctor tried this after everything else has failed. It didn't work, in fact it did nothing good what so ever. My CEA went from 479 to over 2000, the highest it has been since I got cancer in 2016. It might work for some but I haven't heard of it benefitting anyone. Good luck to those who use it."